?-Interferon Market - Global Outlook and Forecast 2022-2028

January 2022 | 62 pages | ID: BDF078282EE4EN
Market Monitor Global

Abstracts

?-Interferon is a type I interferon. It is produced by various cells such as fibroblasts after induction by viruses and nucleic acids.

This report contains market size and forecasts of ?-Interferon in Global, including the following market information:

Global ?-Interferon Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global ?-Interferon market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of ?-Interferon include Merck, Roche, SP (Brinny) Company, Anke Bio, Sinopharm, Kexing Biopharm, Kawin, Hainan Unipul Pharmaceutical and Tri-Prime Gene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ?-Interferon companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global ?-Interferon Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global ?-Interferon Market Segment Percentages, by Type, 2021 (%)

• Injection
• Topical

Global ?-Interferon Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global ?-Interferon Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Drug Store
• Others

Global ?-Interferon Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global ?-Interferon Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies ?-Interferon revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies ?-Interferon revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Roche
• SP (Brinny) Company
• Anke Bio
• Sinopharm
• Kexing Biopharm
• Kawin
• Hainan Unipul Pharmaceutical
• Tri-Prime Gene
• Amoytop Biotech
• Changchun Institute of Biological Products

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 ?-Interferon Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global ?-Interferon Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ?-INTERFERON OVERALL MARKET SIZE

2.1 Global ?-Interferon Market Size: 2021 VS 2028
2.2 Global ?-Interferon Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top ?-Interferon Players in Global Market
3.2 Top Global ?-Interferon Companies Ranked by Revenue
3.3 Global ?-Interferon Revenue by Companies
3.4 Top 3 and Top 5 ?-Interferon Companies in Global Market, by Revenue in 2021
3.5 Global Companies ?-Interferon Product Type
3.6 Tier 1, Tier 2 and Tier 3 ?-Interferon Players in Global Market
  3.6.1 List of Global Tier 1 ?-Interferon Companies
  3.6.2 List of Global Tier 2 and Tier 3 ?-Interferon Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global ?-Interferon Market Size Markets, 2021 & 2028
  4.1.2 Injection
  4.1.3 Topical
4.2 By Type - Global ?-Interferon Revenue & Forecasts
  4.2.1 By Type - Global ?-Interferon Revenue, 2017-2022
  4.2.2 By Type - Global ?-Interferon Revenue, 2023-2028
  4.2.3 By Type - Global ?-Interferon Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global ?-Interferon Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinics
  5.1.4 Drug Store
  5.1.5 Others
5.2 By Application - Global ?-Interferon Revenue & Forecasts
  5.2.1 By Application - Global ?-Interferon Revenue, 2017-2022
  5.2.2 By Application - Global ?-Interferon Revenue, 2023-2028
  5.2.3 By Application - Global ?-Interferon Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global ?-Interferon Market Size, 2021 & 2028
6.2 By Region - Global ?-Interferon Revenue & Forecasts
  6.2.1 By Region - Global ?-Interferon Revenue, 2017-2022
  6.2.2 By Region - Global ?-Interferon Revenue, 2023-2028
  6.2.3 By Region - Global ?-Interferon Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America ?-Interferon Revenue, 2017-2028
  6.3.2 US ?-Interferon Market Size, 2017-2028
  6.3.3 Canada ?-Interferon Market Size, 2017-2028
  6.3.4 Mexico ?-Interferon Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe ?-Interferon Revenue, 2017-2028
  6.4.2 Germany ?-Interferon Market Size, 2017-2028
  6.4.3 France ?-Interferon Market Size, 2017-2028
  6.4.4 U.K. ?-Interferon Market Size, 2017-2028
  6.4.5 Italy ?-Interferon Market Size, 2017-2028
  6.4.6 Russia ?-Interferon Market Size, 2017-2028
  6.4.7 Nordic Countries ?-Interferon Market Size, 2017-2028
  6.4.8 Benelux ?-Interferon Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia ?-Interferon Revenue, 2017-2028
  6.5.2 China ?-Interferon Market Size, 2017-2028
  6.5.3 Japan ?-Interferon Market Size, 2017-2028
  6.5.4 South Korea ?-Interferon Market Size, 2017-2028
  6.5.5 Southeast Asia ?-Interferon Market Size, 2017-2028
  6.5.6 India ?-Interferon Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America ?-Interferon Revenue, 2017-2028
  6.6.2 Brazil ?-Interferon Market Size, 2017-2028
  6.6.3 Argentina ?-Interferon Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa ?-Interferon Revenue, 2017-2028
  6.7.2 Turkey ?-Interferon Market Size, 2017-2028
  6.7.3 Israel ?-Interferon Market Size, 2017-2028
  6.7.4 Saudi Arabia ?-Interferon Market Size, 2017-2028
  6.7.5 UAE ?-Interferon Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck ?-Interferon Major Product Offerings
  7.1.4 Merck ?-Interferon Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche ?-Interferon Major Product Offerings
  7.2.4 Roche ?-Interferon Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 SP (Brinny) Company
  7.3.1 SP (Brinny) Company Corporate Summary
  7.3.2 SP (Brinny) Company Business Overview
  7.3.3 SP (Brinny) Company ?-Interferon Major Product Offerings
  7.3.4 SP (Brinny) Company ?-Interferon Revenue in Global Market (2017-2022)
  7.3.5 SP (Brinny) Company Key News
7.4 Anke Bio
  7.4.1 Anke Bio Corporate Summary
  7.4.2 Anke Bio Business Overview
  7.4.3 Anke Bio ?-Interferon Major Product Offerings
  7.4.4 Anke Bio ?-Interferon Revenue in Global Market (2017-2022)
  7.4.5 Anke Bio Key News
7.5 Sinopharm
  7.5.1 Sinopharm Corporate Summary
  7.5.2 Sinopharm Business Overview
  7.5.3 Sinopharm ?-Interferon Major Product Offerings
  7.5.4 Sinopharm ?-Interferon Revenue in Global Market (2017-2022)
  7.5.5 Sinopharm Key News
7.6 Kexing Biopharm
  7.6.1 Kexing Biopharm Corporate Summary
  7.6.2 Kexing Biopharm Business Overview
  7.6.3 Kexing Biopharm ?-Interferon Major Product Offerings
  7.6.4 Kexing Biopharm ?-Interferon Revenue in Global Market (2017-2022)
  7.6.5 Kexing Biopharm Key News
7.7 Kawin
  7.7.1 Kawin Corporate Summary
  7.7.2 Kawin Business Overview
  7.7.3 Kawin ?-Interferon Major Product Offerings
  7.7.4 Kawin ?-Interferon Revenue in Global Market (2017-2022)
  7.7.5 Kawin Key News
7.8 Hainan Unipul Pharmaceutical
  7.8.1 Hainan Unipul Pharmaceutical Corporate Summary
  7.8.2 Hainan Unipul Pharmaceutical Business Overview
  7.8.3 Hainan Unipul Pharmaceutical ?-Interferon Major Product Offerings
  7.8.4 Hainan Unipul Pharmaceutical ?-Interferon Revenue in Global Market (2017-2022)
  7.8.5 Hainan Unipul Pharmaceutical Key News
7.9 Tri-Prime Gene
  7.9.1 Tri-Prime Gene Corporate Summary
  7.9.2 Tri-Prime Gene Business Overview
  7.9.3 Tri-Prime Gene ?-Interferon Major Product Offerings
  7.9.4 Tri-Prime Gene ?-Interferon Revenue in Global Market (2017-2022)
  7.9.5 Tri-Prime Gene Key News
7.10 Amoytop Biotech
  7.10.1 Amoytop Biotech Corporate Summary
  7.10.2 Amoytop Biotech Business Overview
  7.10.3 Amoytop Biotech ?-Interferon Major Product Offerings
  7.10.4 Amoytop Biotech ?-Interferon Revenue in Global Market (2017-2022)
  7.10.5 Amoytop Biotech Key News
7.11 Changchun Institute of Biological Products
  7.11.1 Changchun Institute of Biological Products Corporate Summary
  7.11.2 Changchun Institute of Biological Products Business Overview
  7.11.3 Changchun Institute of Biological Products ?-Interferon Major Product Offerings
  7.11.4 Changchun Institute of Biological Products ?-Interferon Revenue in Global Market (2017-2022)
  7.11.5 Changchun Institute of Biological Products Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. ?-Interferon Market Opportunities & Trends in Global Market
Table 2. ?-Interferon Market Drivers in Global Market
Table 3. ?-Interferon Market Restraints in Global Market
Table 4. Key Players of ?-Interferon in Global Market
Table 5. Top ?-Interferon Players in Global Market, Ranking by Revenue (2021)
Table 6. Global ?-Interferon Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global ?-Interferon Revenue Share by Companies, 2017-2022
Table 8. Global Companies ?-Interferon Product Type
Table 9. List of Global Tier 1 ?-Interferon Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 ?-Interferon Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global ?-Interferon Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - ?-Interferon Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - ?-Interferon Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global ?-Interferon Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - ?-Interferon Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - ?-Interferon Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global ?-Interferon Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global ?-Interferon Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global ?-Interferon Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America ?-Interferon Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America ?-Interferon Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe ?-Interferon Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe ?-Interferon Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia ?-Interferon Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia ?-Interferon Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America ?-Interferon Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America ?-Interferon Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa ?-Interferon Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa ?-Interferon Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck ?-Interferon Product Offerings
Table 32. Merck ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche ?-Interferon Product Offerings
Table 35. Roche ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 36. SP (Brinny) Company Corporate Summary
Table 37. SP (Brinny) Company ?-Interferon Product Offerings
Table 38. SP (Brinny) Company ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 39. Anke Bio Corporate Summary
Table 40. Anke Bio ?-Interferon Product Offerings
Table 41. Anke Bio ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 42. Sinopharm Corporate Summary
Table 43. Sinopharm ?-Interferon Product Offerings
Table 44. Sinopharm ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 45. Kexing Biopharm Corporate Summary
Table 46. Kexing Biopharm ?-Interferon Product Offerings
Table 47. Kexing Biopharm ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 48. Kawin Corporate Summary
Table 49. Kawin ?-Interferon Product Offerings
Table 50. Kawin ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 51. Hainan Unipul Pharmaceutical Corporate Summary
Table 52. Hainan Unipul Pharmaceutical ?-Interferon Product Offerings
Table 53. Hainan Unipul Pharmaceutical ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 54. Tri-Prime Gene Corporate Summary
Table 55. Tri-Prime Gene ?-Interferon Product Offerings
Table 56. Tri-Prime Gene ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 57. Amoytop Biotech Corporate Summary
Table 58. Amoytop Biotech ?-Interferon Product Offerings
Table 59. Amoytop Biotech ?-Interferon Revenue (US$, Mn), (2017-2022)
Table 60. Changchun Institute of Biological Products Corporate Summary
Table 61. Changchun Institute of Biological Products ?-Interferon Product Offerings
Table 62. Changchun Institute of Biological Products ?-Interferon Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. ?-Interferon Segment by Type in 2021
Figure 2. ?-Interferon Segment by Application in 2021
Figure 3. Global ?-Interferon Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global ?-Interferon Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global ?-Interferon Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by ?-Interferon Revenue in 2021
Figure 8. By Type - Global ?-Interferon Revenue Market Share, 2017-2028
Figure 9. By Application - Global ?-Interferon Revenue Market Share, 2017-2028
Figure 10. By Region - Global ?-Interferon Revenue Market Share, 2017-2028
Figure 11. By Country - North America ?-Interferon Revenue Market Share, 2017-2028
Figure 12. US ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 13. Canada ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe ?-Interferon Revenue Market Share, 2017-2028
Figure 16. Germany ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 17. France ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 19. Italy ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 20. Russia ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia ?-Interferon Revenue Market Share, 2017-2028
Figure 24. China ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 25. Japan ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 28. India ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America ?-Interferon Revenue Market Share, 2017-2028
Figure 30. Brazil ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa ?-Interferon Revenue Market Share, 2017-2028
Figure 33. Turkey ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 34. Israel ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 36. UAE ?-Interferon Revenue, (US$, Mn), 2017-2028
Figure 37. Merck ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. SP (Brinny) Company ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Anke Bio ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sinopharm ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kexing Biopharm ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Kawin ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hainan Unipul Pharmaceutical ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Tri-Prime Gene ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Amoytop Biotech ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Changchun Institute of Biological Products ?-Interferon Revenue Year Over Year Growth (US$, Mn) & (2017-2022)